porcin
epidem
diarrhea
viru
pedv
member
genu
alphacoronaviru
belong
famili
coronavirida
order
nidoviral
pedv
larg
envelop
viru
possess
cap
singlestrand
positivesens
rna
genom
approxim
kb
polyadenyl
tail
pedv
genom
consist
seven
canon
gene
includ
open
read
frame
orf
flank
region
utr
first
two
larg
orf
compris
twothird
genom
encod
replicas
polyprotein
posttransl
cleav
matur
nonstructur
protein
last
onethird
encod
four
canon
coronaviru
structur
protein
fix
order
spike
membran
envelop
e
nucleocapsid
n
well
singl
accessori
gene
encod
viru
phylogenet
divid
two
genotyp
compris
two
subgenotyp
genogroup
classic
recombin
lowpathogen
genogroup
local
epidem
global
epidem
pandem
highpathogen
pedv
caus
acut
gastrointestin
symptom
character
rapid
onset
sever
wateri
diarrhea
vomit
fatal
dehydr
high
mortal
newborn
suckl
piglet
viru
initi
recogn
england
sinc
geograph
restrict
problemat
europ
asia
past
four
decad
howev
earli
pedv
first
emerg
unit
state
rapidli
spread
adjac
north
south
american
countri
caus
signific
financi
loss
swine
industri
soon
us
prototypelik
highli
virul
pedv
strain
almost
simultan
invad
multipl
asian
nation
includ
south
korea
taiwan
japan
result
recurr
massiv
nationwid
ped
epizoot
pedv
emerg
reemerg
one
devast
porcin
virus
pose
tremend
threat
global
pork
busi
challeng
substanti
monetari
damag
caus
pedv
highlight
exig
necess
establish
optim
immun
strategi
case
porcin
enter
virus
produc
clinic
diseas
newborn
piglet
develop
activ
immun
neonat
protect
passiv
lactogen
immun
deriv
dam
prophylact
matern
immun
regimen
oral
live
virus
includ
intent
infect
vaccin
sow
gestat
remain
effect
way
stimul
intestin
mucos
immun
subsequ
transfer
piglet
via
mammari
secret
although
intent
infect
feedback
control
oral
exposur
extens
use
induc
herd
immun
sever
potenti
risk
associ
practic
wide
dissemin
microbi
pathogen
uncertainti
immun
induct
therefor
numer
research
group
attempt
develop
safer
effect
live
attenu
pedv
vaccin
induc
passiv
lactogen
immun
altern
intent
infect
south
korea
number
modifi
live
viru
mlv
vaccin
classic
pedv
came
wide
use
throughout
countri
howev
incap
control
impact
recent
massiv
outbreak
domest
swine
industri
limit
crossprotect
two
genet
cluster
consid
efficaci
issu
high
prioriti
develop
nextgener
mlv
vaccin
epizoot
relat
strain
preval
field
replic
high
titer
gut
also
boost
lactogen
immun
respons
without
give
rise
clinic
ill
gener
attenu
viru
util
prepar
mlv
vaccin
achiev
tradit
cell
cultur
adapt
procedur
virul
wildtyp
viru
nonhost
cell
line
process
imped
difficulti
perform
laboratori
procedur
numer
timeconsum
repetit
passag
nonhost
cell
line
contrast
adapt
growth
low
temperatur
shortterm
serial
passag
vitro
frequent
use
gener
sever
attenu
dna
rna
virus
studi
sought
creat
coldadapt
attenu
pedv
lowpassag
strain
progress
decreas
growth
temperatur
vero
cell
attempt
evalu
protect
efficaci
neonat
piglet
virul
pedv
challeng
vero
cell
atcc
cultur
alpha
minimum
essenti
medium
invitrogen
usa
fetal
bovin
serum
fb
invitrogen
antibioticantimycot
solut
invitrogen
maintain
humidifi
incub
isol
highli
virul
korean
pedv
strain
conduct
clinic
fecal
sampl
vero
cell
presenc
trypsin
usb
usa
viru
isol
confirm
cytopath
effect
cpe
observ
immunofluoresc
assay
ifa
nucleotid
sequenc
describ
previous
viral
stock
prepar
passag
cell
cultur
use
parent
challeng
viru
studi
pedv
n
proteinspecif
monoclon
antibodi
mab
obtain
choongang
vaccin
laboratori
cavac
korea
pedv
strain
plaquepurifi
twice
vero
cell
purifi
viru
serial
passag
vero
cell
gradual
reduc
incub
temperatur
describ
previous
modif
confluent
vero
cell
grown
diamet
tissu
cultur
dish
wash
pb
inocul
pedv
along
trypsin
incub
h
viru
growth
medium
bmprov
medium
cell
scienc
technolog
institut
inc
japan
supplement
trypsin
ad
inocul
cell
maintain
monitor
daili
cpe
cell
show
cpe
inocul
cell
subject
three
round
freez
thaw
cultur
supernat
centrifug
min
g
hanil
centrifug
korea
filter
pores
filter
millipor
usa
clarifi
supernat
aliquot
store
viral
stock
next
passag
manner
passag
time
stepwis
descend
temperatur
per
passag
vero
cell
subsequ
serial
cultiv
addit
passag
cold
adapt
viru
stock
produc
passag
design
vero
cell
infect
aram
viru
stock
presenc
trypsin
describ
cultur
supernat
collect
h
postinfect
hpi
cpe
commonli
develop
viru
titer
measur
endpoint
titrat
plate
use
serial
dilut
supernat
sampl
triplic
dilut
determin
amount
viru
requir
produc
cpe
inocul
vero
cell
tissu
cultur
infecti
dose
per
ml
viru
stock
calcul
use
reed
muench
method
fulllength
genom
sequenc
parent
coldadapt
strain
determin
tradit
sanger
method
ten
overlap
cdna
fragment
span
entir
genom
viru
strain
amplifi
sequenc
describ
elsewher
end
genom
strain
determin
rapid
amplif
cdna
end
race
describ
previous
fulllength
genom
sequenc
deposit
genbank
databas
access
number
sequenc
fulli
sequenc
gene
complet
genom
global
pedv
isol
independ
use
sequenc
align
phylogenet
analys
multipl
sequenc
align
gener
use
clustalx
program
percentag
nucleotid
sequenc
diverg
assess
use
softwar
phylogenet
tree
construct
align
nucleotid
amino
acid
sequenc
use
neighborjoin
method
subsequ
subject
bootstrap
analysi
replic
determin
percentag
reliabl
valu
intern
node
tree
phylogenet
tree
gener
use
mega
softwar
four
vivo
swine
studi
describ
independ
perform
cavac
anim
facil
guidelin
establish
institut
anim
care
use
committe
iacuc
approv
anim
obtain
convent
breed
farm
good
health
record
either
vaccin
pedv
known
prior
ped
outbreak
test
confirm
infect
porcin
enter
virus
piglet
challeng
trial
conduct
determin
infecti
dose
virul
pedv
aram
strain
use
convent
suckl
piglet
deliv
commerci
crossbr
sow
great
yorkshir
dutch
landrac
thirti
pig
divid
six
group
group
five
anim
fed
commerci
milk
replac
frequent
time
daili
ad
libitum
access
water
studi
day
anim
group
allow
acclim
two
day
inocul
oral
ml
dilut
viru
cell
cultur
medium
day
age
respect
inocul
piglet
observ
daili
clinic
sign
includ
diarrhea
mortal
stool
sampl
pig
group
collect
prior
inocul
daili
cottontip
swab
score
fecal
consist
day
postinocul
dpi
normal
pasti
semiliquid
liquid
wateri
mean
pig
diarrhea
dose
lethal
dose
determin
reciproc
viru
dilut
pig
develop
wateri
diarrhea
score
die
given
time
point
use
reed
muench
method
assess
immunogen
coldadapt
deriv
total
convent
piglet
deliv
commerci
crossbr
sow
great
yorkshir
dutch
landrac
alloc
cold
adapt
n
n
n
n
shaminocul
control
n
group
anim
immun
oral
ml
dose
viru
sham
inocul
cell
cultur
medium
preimmun
sera
collect
immun
antisera
collect
week
interv
week
pathogen
test
perform
use
total
suckl
piglet
day
age
obtain
commerci
crossbr
sow
great
yorkshir
dutch
landrac
pig
randomli
assign
three
experiment
group
parent
n
coldadapt
n
shaminocul
control
n
group
anim
fed
commerci
milk
replac
frequent
time
daili
ad
libitum
access
water
durat
studi
day
acclim
period
piglet
virusinocul
group
receiv
ml
dose
equival
determin
studi
one
virus
oral
shaminocul
pig
administ
cell
cultur
medium
placebo
anim
monitor
daili
clinic
sign
vomit
diarrhea
mortal
throughout
experi
rectal
swab
collect
pig
dilut
pb
wv
suspens
follow
centrifug
clarifi
supernat
subject
convent
revers
transcript
polymeras
chain
reaction
rtpcr
use
itgep
detect
kit
intron
biotechnolog
korea
realtim
rtpcr
detect
presenc
pedv
shed
clinic
signific
score
css
determin
follow
score
criteria
base
visual
examin
dpi
use
measur
diarrheal
sever
normal
diarrhea
mean
cycl
threshold
ct
valu
mild
fluidic
fece
moder
wateri
diarrhea
sever
wateri
projectil
diarrhea
mean
ct
valu
death
piglet
necropsi
upon
death
challeng
throughout
studi
wherea
surviv
pig
challeng
control
group
euthan
dpi
postmortem
examin
swine
vaccin
challeng
experi
conduct
total
commerci
crossbr
pregnant
sow
great
yorkshir
dutch
landrac
pariti
expect
farrow
date
anim
alloc
randomli
three
experiment
group
vaccin
group
n
challeng
control
group
n
strict
neg
control
group
n
multipledos
ped
homolog
vaccin
schedul
interv
start
prior
farrow
appli
present
protect
studi
three
sow
group
oral
administ
twice
ml
dose
week
prepartum
remain
sow
group
unvaccin
serv
control
sow
monitor
daili
clinic
alter
advers
effect
follow
vaccin
mimic
field
condit
nurs
piglet
sow
allow
farrow
natur
nurs
piglet
freeli
durat
studi
ten
suckl
piglet
per
litter
total
newborn
piglet
group
challeng
oral
ml
dose
virul
viru
shaminocul
piglet
group
administ
cell
cultur
medium
placebo
anim
observ
daili
clinic
sign
includ
vomit
diarrhea
mortal
fecal
specimen
taken
group
examin
pedv
shed
describ
css
determin
day
postchalleng
dpc
describ
blood
sampl
collect
sow
vaccin
farrow
week
also
repres
piglet
per
litter
dam
dpc
colostrum
collect
day
farrow
viral
rna
extract
fecal
suspens
prepar
describ
use
itgep
detect
kit
accord
manufactur
protocol
quantit
realtim
rtpcr
perform
use
one
step
sybr
primescript
rtpcr
kit
takara
japan
describ
elsewher
pedv
isol
known
infect
titer
serial
dilut
gener
standard
curv
pcr
plate
viru
concentr
sampl
calcul
base
standard
curv
mean
ct
valu
calcul
base
pcr
posit
sampl
mean
viru
titer
calcul
base
pig
within
group
intestin
tissu
major
organ
grossli
examin
upon
necropsi
small
intestin
tissu
specimen
thick
collect
piglet
fix
formalin
h
rt
embed
paraffin
accord
standard
laboratori
procedur
formalinfix
paraffinembed
tissu
cut
thick
section
microtom
leica
germani
float
water
bath
contain
distil
water
transfer
glass
slide
deparaffin
intestin
tissu
section
stain
hematoxylin
eosin
sigma
usa
observ
histopatholog
chang
subject
immunohistochemistri
ihc
detect
pedv
antigen
use
mab
specif
pedv
n
protein
describ
previous
pedv
antigen
detect
semiquantit
measur
throughout
ihcstain
jejun
section
base
follow
score
criteria
describ
previous
signal
villou
enterocyt
within
section
show
posit
signal
villou
enterocyt
show
posit
signal
greater
villou
enterocyt
show
posit
signal
presenc
pedvspecif
neutral
antibodi
serum
colostrum
sampl
collect
pig
group
determin
use
serum
neutral
sn
test
use
pedv
isol
previous
describ
neutral
titer
calcul
reciproc
highest
dilut
serum
inhibit
virusspecif
cpe
duplic
well
valu
express
mean
standard
deviat
mean
sdm
statist
signific
evalu
student
ttest
use
graphpad
prism
softwar
version
graphpad
prism
inc
usa
p
valu
less
consid
statist
signific
pedv
isol
cell
cultur
first
step
toward
gener
live
attenu
vaccin
thu
initi
attempt
isol
pedv
clinic
fecal
suspens
success
propag
one
korean
pedv
strain
design
aram
vero
cell
aram
strain
produc
obviou
cpe
typic
pedv
infect
cell
fusion
multinucl
cell
syncytium
format
infect
vero
cell
verifi
detect
pedv
antigen
ifa
use
pedv
n
proteinspecif
mab
fig
growth
kinet
analysi
indic
aram
replic
effici
vero
cell
reach
maximum
viral
titer
hpi
fig
subsequ
determin
entir
genom
sequenc
origin
fecal
sampl
aramfec
cell
culturepassag
viru
use
sanger
technolog
identifi
genom
ident
length
nt
except
poli
tail
show
typic
genom
organ
alphacoronavirus
consist
utr
nt
nt
gene
nt
nt
e
gene
nt
membran
gene
nt
n
gene
nt
utr
compar
complet
genom
sequenc
aramfec
viru
amino
acid
aa
substitut
throughout
entir
genom
suggest
genet
stabil
cell
passag
interestingli
genom
size
aram
strain
shorter
field
virus
due
presenc
uniqu
delet
del
genom
posit
respect
del
complet
absent
genom
sequenc
global
strain
avail
genbank
databas
former
del
result
del
aa
posit
ntermin
domain
ntd
protein
fig
latter
thymin
residu
del
nt
posit
caus
prematur
termin
upstream
authent
stop
codon
therebi
possibl
produc
truncat
without
ctermin
residu
fig
sequenc
analysi
complet
gene
show
aram
strain
classifi
share
aa
ident
global
strain
aa
homolog
classic
variant
strain
respect
likewis
aram
isol
high
degre
nt
homolog
global
pedv
genom
level
howev
genet
distinct
strain
show
rel
low
nt
ident
rang
furthermor
aram
strain
possess
genet
signatur
epidem
strain
insertionsdelet
indel
within
ntermin
hypervari
region
compar
prototyp
strain
fig
phylogenet
analysi
base
complet
protein
clearli
classifi
pedv
strain
two
distinct
genogroup
cluster
two
subgroup
genogroup
fig
aram
strain
belong
subgroup
cluster
close
contemporari
domest
global
isol
subsequ
wholegenom
phylogeni
show
group
structur
genebas
phylogenet
tree
fig
pedv
stock
known
cell
cultur
infecti
titer
serial
dilut
cell
cultur
medium
give
rise
theoret
infecti
titer
dilut
respect
later
use
determin
outcom
infect
piglet
tabl
group
group
five
piglet
challeng
oral
serial
dilut
viru
control
anim
group
fed
cell
cultur
medium
five
piglet
group
inocul
viru
dilut
three
piglet
group
inocul
viru
dilut
develop
moder
wateri
diarrhea
score
dpi
last
studi
period
tabl
dpi
pig
group
pig
group
pig
group
die
pedrel
clinic
sign
contrast
five
pig
group
inocul
viru
dilut
neg
control
group
remain
activ
clinic
unaffect
throughout
experiment
period
aram
viru
determin
indirectli
correspond
theoret
cell
cultur
infecti
titer
respect
coldadapt
pedv
aramca
strain
gener
serial
passag
low
temperatur
commenc
addit
adapt
growth
passag
vero
cell
initi
aim
evalu
immunogen
coldadapt
aram
deriv
natur
host
antisera
collect
pig
oral
administr
viru
test
neutral
activ
aram
isol
serum
sampl
obtain
pig
immun
coldadapt
strain
higher
neutral
antibodi
titer
compar
pig
ca
virusinocul
group
fig
furthermor
immun
sera
pig
inocul
strain
show
littl
neutral
activ
pedv
sinc
data
indic
elicit
robust
antibodi
respons
immun
anim
coldadapt
viru
select
subsequ
vitro
vivo
studi
like
parent
viru
shown
fig
coldadapt
strain
caus
notic
cpe
ifa
stain
show
typic
syncytia
virusinfect
cell
howev
viru
show
delay
replic
late
cpe
onset
compar
indic
impair
growth
diminish
growth
confirm
compar
growth
kinet
vero
cell
temperatur
strain
exhibit
effici
growth
infecti
titer
dpi
slower
replic
rate
maximum
titer
parent
strain
reduct
indic
adapt
low
temperatur
identifi
mutat
occur
cold
adapt
pedv
genom
coldadapt
viru
sequenc
compar
wildtyp
viru
addit
indel
found
genom
cold
adapt
genom
size
strain
determin
ident
parent
genom
size
two
genet
del
marker
aram
strain
also
complet
conserv
coldadapt
strain
fig
utr
coldadapt
viru
remain
unchang
wherea
code
region
contain
total
nt
substitut
fig
among
mutat
nonsynonym
caus
chang
e
detail
nt
aa
differ
parent
coldadapt
strain
summar
tabl
phylogenet
analysi
base
fulllength
entir
genom
indic
coldadapt
strain
still
cluster
subgroup
along
parent
global
epizoot
strain
fig
next
anim
inocul
experi
perform
examin
vivo
phenotyp
alter
associ
serial
vitro
passag
low
temperatur
cold
adapt
tool
viru
attenu
virul
aram
strain
pathogen
parent
coldadapt
deriv
character
pig
twelv
piglet
divid
three
group
four
anim
challeng
oral
parent
group
coldadapt
group
remain
piglet
control
group
receiv
cell
cultur
medium
clinic
sign
record
daili
fecal
swab
collect
pre
postchalleng
durat
studi
acclim
period
piglet
activ
show
clinic
symptom
normal
fecal
consist
contain
pedv
genet
materi
challeng
none
negativecontrol
piglet
develop
clinic
present
typic
pedv
throughout
studi
contrast
piglet
group
display
clinic
sign
includ
loss
appetit
diarrheic
fece
dpi
mean
css
sdm
underw
lethal
wateri
diarrhea
vomit
thereaft
mean
css
fig
inocul
anim
group
final
die
dpi
remark
coldadapt
virusinocul
piglet
group
experienc
neither
pedvrel
clinic
symptom
mortal
throughout
experi
anim
group
posit
pedv
determin
rtpcr
dpi
mean
ct
valu
equival
shed
significantli
higher
amount
pedv
fece
ct
rang
death
fig
likewis
fecal
shed
pedv
detect
piglet
group
dpi
mean
ct
valu
thereaft
decreas
lowest
level
thereaft
follow
slight
increas
dpi
overal
quantiti
virus
fece
anim
group
significantli
declin
compar
group
wide
ct
rang
termin
studi
indic
limit
shed
almost
reduct
strain
neg
control
piglet
remain
activ
without
onset
diarrhea
pedv
fecal
shed
throughout
experiment
period
anim
parent
group
necropsi
upon
death
dpi
piglet
remain
group
euthan
end
studi
postmortem
examin
fig
neither
macroscop
microscop
intestin
lesion
evid
neg
control
piglet
right
panel
c
f
virul
pig
macroscop
show
archetyp
pedlik
gross
lesion
small
intestin
dilat
accumul
yellowish
fecal
fluid
thin
transpar
wall
result
villou
atrophi
panel
wherea
intern
organ
appear
normal
contrast
anim
infect
coldadapt
group
display
remark
visibl
patholog
lesion
gastrointestin
tract
normal
bowel
wall
thick
compar
neg
control
group
panel
b
microscop
assess
reveal
small
intestin
dead
piglet
group
character
acut
viral
enter
villou
shorten
fusion
involv
vacuol
superfici
epitheli
cell
jejunum
panel
furthermor
ihc
stain
show
intens
antigen
label
cytoplasm
epitheli
cell
atrophi
intestin
villi
immunosign
score
mean
sdm
jejunum
panel
g
howev
two
four
coldadapt
virusinocul
pig
group
exhibit
mild
villou
atrophi
small
intestin
remain
pig
show
normal
intestin
histopatholog
panel
e
analog
neg
control
group
panel
f
pedv
antigen
rare
present
small
intestin
anim
group
significantli
lower
mean
jejun
viral
antigen
score
panel
h
group
panel
g
altogeth
result
indic
coldadapt
show
notic
weaken
virul
attenu
phenotyp
highli
suscept
piglet
experiment
condit
evalu
protect
effect
coldadapt
pedv
vaccin
studi
employ
oral
homolog
primeboost
vaccin
scheme
week
apart
farrow
three
sow
group
oral
prime
boost
live
vaccin
week
prepartum
wherea
posit
group
neg
group
control
anim
kept
unvaccin
sow
vaccin
unvaccin
group
experienc
neither
pedlik
clinic
symptom
includ
pedv
fecal
shed
advers
reaction
vaccin
farrow
signific
differ
reproduct
perform
vaccin
unvaccin
sow
ten
piglet
per
litter
alloc
sow
nurs
dam
day
postfarrow
neonat
group
oral
expos
virul
viru
contrast
nurs
piglet
group
mockinocul
mem
clinic
sign
record
daili
fecal
swab
collect
challeng
durat
studi
prechalleng
period
piglet
healthi
clinic
symptom
show
normal
fecal
consist
without
pedv
shed
follow
challeng
pedvexpos
piglet
unvaccin
sow
group
develop
clinic
symptom
includ
anorexia
diarrhea
dpc
mean
css
suffer
sever
wateri
diarrhea
vomit
thereaft
fig
howev
piglet
vaccin
sow
group
mild
diarrhea
mean
css
rang
throughout
challeng
period
result
demonstr
litter
vaccin
sow
significantli
mitig
diarrhea
challeng
compar
unvaccin
sow
pedvassoci
mortal
occur
piglet
unvaccin
sow
dpi
addit
fatal
occur
end
studi
indic
rate
mortal
unvaccin
challeng
control
group
fig
contrast
piglet
birth
vaccin
sow
group
die
pedv
exposur
show
approxim
surviv
rate
piglet
pedv
fecal
shed
detect
piglet
unvaccin
sow
group
dpc
persist
discharg
high
quantiti
pedv
fece
death
fig
howev
anim
vaccin
sow
group
show
pedv
shed
fece
dpi
peak
mean
titer
amount
fecal
shed
significantli
declin
thereaft
piglet
neg
control
sow
group
remain
aliv
viral
shed
rectal
swab
durat
studi
consid
neutral
antibodi
associ
protect
immun
neonat
pedv
infect
test
serum
colostrum
sampl
collect
sow
neonat
piglet
presenc
antipedv
antibodi
sn
assay
shown
fig
sow
develop
antipedv
neutral
antibodi
live
prime
vaccin
thereaft
neutral
antibodi
titer
sera
vaccin
sow
gradual
increas
like
result
homolog
boost
three
sow
maintain
high
neutral
antibodi
titer
week
postfarrow
consist
result
serum
sampl
neutral
antibodi
level
significantli
high
colostrum
vaccin
sow
fig
furthermor
nurs
piglet
litter
group
prechalleng
neutral
antibodi
level
similar
dam
retain
antibodi
dpi
indic
protect
effect
lactogen
immun
passiv
acquir
vaccin
sow
fig
contrast
none
unvaccin
sow
piglet
show
antipedv
neutral
antibodi
serum
colostrum
sampl
group
taken
togeth
data
demonstr
oral
vaccin
coldadapt
live
attenu
viru
effici
elicit
potent
antibodi
respons
sow
subsequ
transfer
offspr
via
milk
provid
protect
pedv
sow
possess
mean
transplacent
transmit
matern
immunoglobulin
fetu
henc
piglet
born
without
passiv
immun
protect
highli
suscept
varieti
infecti
agent
particularli
multipl
enter
pathogen
pedv
substitut
passiv
immun
depend
supplement
maternalderiv
immun
compon
via
mammari
secret
ie
colostrum
milk
therefor
matern
vaccin
crucial
effect
tool
confer
passiv
protect
newborn
piglet
lactogen
immun
pedv
infect
object
may
accomplish
select
ideal
vaccin
candid
antigen
close
epidem
strain
virul
minim
absent
piglet
south
korea
sever
pedvbas
live
vaccin
extens
employ
prevent
ped
decad
howev
owe
partial
protect
histor
vaccin
contemporari
strain
prevail
sinc
pandem
demand
develop
new
effect
vaccin
base
domin
epidem
strain
increas
although
effort
pioneer
new
mlv
vaccin
made
past
sever
year
success
delay
experiment
hurdl
labori
longterm
attenu
procedur
cell
cultur
acknowledg
cold
adapt
anim
virus
serial
reduc
temperatur
cultiv
best
method
deriv
live
viru
vaccin
line
gener
accompani
loss
virul
studi
use
cold
adapt
approach
stepwis
lower
cultiv
temperatur
vitro
pedv
attenu
aim
determin
immunogen
pathogen
coldadapt
strain
efficaci
attenu
live
vaccin
candid
experiment
condit
pandem
pedv
strain
ravag
global
swine
industri
pedv
field
move
toward
develop
novel
vaccin
vaccin
strategi
accomplish
task
first
isol
field
pedv
effici
propag
vitro
isol
exhibit
compar
growth
characterist
strain
regard
cytopatholog
infecti
titer
replic
kinet
vero
cell
report
previous
genet
phylogenet
analys
show
aram
isol
close
relat
recent
strain
preval
worldwid
howev
sequenc
comparison
pedv
strain
reveal
outstand
genom
featur
aram
strain
natur
includ
two
independ
del
respect
interestingli
due
del
aram
predict
encod
altern
protein
larg
excis
cterminu
although
exact
function
pedv
remain
unknown
number
attenu
pedv
strain
contain
signatur
del
sever
part
suggest
critic
role
viral
pathogenesi
particular
wang
et
al
report
attenu
pedv
encod
ctermin
truncat
protein
residu
form
analog
aram
strain
howev
experiment
oral
inocul
newborn
pig
induc
sever
clinic
present
macroscop
microscop
intestin
lesion
typic
acut
pedv
infect
report
previous
gener
death
rate
averag
suckl
piglet
one
week
age
often
approach
neonat
less
day
age
decreas
thereaft
likewis
studi
reproduc
mortal
convent
piglet
inocul
oral
dilut
aram
viru
calcul
dose
per
pig
data
demonstr
aram
isol
highli
enteropathogen
neonat
piglet
impli
product
would
irrelev
pedv
virul
sinc
grow
bodi
evid
propos
combin
multipl
genet
mutat
function
nsp
affect
virul
pedv
exclud
ctermin
defect
may
one
molecular
physiolog
factor
may
simultan
alter
pathogen
mechan
howev
consist
previou
work
growth
kinet
aram
strain
cell
cultur
support
notion
accessori
gene
dispens
pedv
replic
vitro
collect
despit
redund
role
viru
propag
vitro
conserv
complet
pedv
field
isol
still
suggest
import
caus
natur
infect
anim
host
serv
novel
mlv
vaccin
strain
gener
aramderiv
attenu
pedv
strain
use
cold
adapt
attenu
method
approach
viral
attenu
obtain
coldadapt
strain
impair
growth
physiolog
temperatur
suffici
induc
mucos
immun
natur
host
coldadapt
strain
deriv
serial
passag
aram
isol
low
temperatur
strain
develop
unsuccess
vitro
infect
physiolog
temperatur
signific
decreas
infecti
unit
observ
howev
viru
show
significantli
high
immunogen
oral
inocul
pig
furthermor
investig
phenotyp
highli
suscept
dayold
piglet
none
inocul
anim
becam
clinic
sick
grossli
abnorm
experiment
data
indic
coldadapt
viru
attenu
virolog
vitro
clinic
vivo
subsequ
sequenc
entir
genom
strain
decod
genet
mutat
emerg
sequenti
cell
passag
upon
cold
adapt
total
nonsil
mutat
aros
orf
except
without
extra
indel
throughout
genom
wherea
two
del
signatur
aram
strain
entir
maintain
intriguingli
substitut
accumul
protein
among
substitut
distribut
nterminu
domain
respect
suggest
chang
associ
viral
attenu
sinc
pedv
protein
heavili
glycosyl
alter
glycan
motif
may
involv
viral
pathogenesi
modifi
protein
conform
function
howev
genet
chang
found
put
nglycosyl
site
parent
coldadapt
strain
major
antigen
determin
glycoprotein
possess
least
four
neutral
domain
pedv
aa
posit
aa
residu
compris
domain
remain
nearli
unchang
throughout
cold
adapt
except
one
mutat
region
furthermor
aa
chang
found
addit
discret
domain
includ
ctermin
domain
residu
interact
cellular
receptor
fusion
domain
compris
hydrophob
fusion
peptid
residu
two
heptad
repeat
region
residu
although
polygen
trait
like
associ
pedv
virul
utmost
import
futur
work
use
revers
genet
technolog
aim
address
whether
genet
drift
especi
protein
influenc
pathogen
pedv
addit
attenu
virus
often
propens
revert
virul
form
certain
circumst
main
drawback
use
mlv
vaccin
inde
strain
abil
replic
sinc
denot
impair
entir
halt
growth
viral
titer
determin
incomplet
abolish
growth
physiolog
temperatur
impli
residu
risk
revers
virul
vivo
thu
safeti
studi
necessari
evalu
phenotyp
stabil
attenu
viru
neonat
piglet
assess
effect
coldadapt
live
attenu
vaccin
homolog
primeboost
sow
immun
trial
consist
oral
administr
doubledos
viru
vaccin
implement
interv
week
deliveri
newborn
piglet
born
vaccin
unvaccin
sow
group
inocul
oral
parent
virul
pedv
strain
differ
burden
diarrheic
diseas
measur
mortal
morbid
investig
challeng
litter
vaccin
unvaccin
sow
piglet
born
unvaccin
sow
present
much
higher
mean
css
determin
intens
diarrhea
vaccin
sow
dpc
challeng
anim
born
vaccin
group
sow
mildtomoder
diarrhea
wherea
piglet
born
unvaccin
group
sow
experienc
fatal
wateri
diarrhea
although
nearli
piglet
group
die
dpc
group
also
exhibit
neonat
mortal
experiment
period
contrari
previou
trial
shown
multipledos
parenter
immun
inactiv
kill
vaccin
kk
vaccin
offer
protect
efficaci
surviv
rate
piglet
viru
present
studi
contrast
piglet
unvaccin
sow
discharg
high
amount
viru
fece
death
pedv
fecal
shed
anim
vaccin
sow
greatli
reduc
dpc
piglet
surviv
shed
viru
stool
end
trial
collect
matern
vaccin
describ
present
studi
unlik
efficaci
kk
treatment
term
protect
rate
howev
could
help
allevi
diarrheal
sever
includ
durat
quantiti
fecal
shed
pedv
although
vaccin
sow
entir
avert
morbid
piglet
upon
pedv
challeng
advantag
effect
reliev
pedv
shed
would
lessen
possibl
environment
contamin
farrow
barn
therebi
break
chain
secondari
spread
viru
anim
herd
epidem
furthermor
pedv
transmiss
via
vaccin
unlik
pedv
genet
materi
detect
fece
pregnant
sow
vaccin
moreov
abl
confirm
presenc
satisfactori
amount
antipedv
neutral
antibodi
sera
colostrum
vaccin
sow
farrow
postfarrow
stage
well
sera
obtain
offspr
indic
piglet
protect
transfer
matern
immun
via
mammari
secret
immun
dam
data
strengthen
concept
optim
vaccin
regimen
associ
retain
high
level
neutral
antibodi
lactogen
secret
vaccin
sow
turn
correl
colostrum
milk
iga
antibodi
titer
offer
protect
immun
pedv
summari
first
report
describ
develop
coldadapt
mlv
vaccin
base
virul
pedv
strain
present
studi
demonstr
loss
virul
highli
pathogen
pedv
strain
genet
mutat
throughout
entir
genom
cold
adapt
vaccinationchalleng
studi
reveal
sow
immun
homolog
oral
matern
vaccin
regimen
provid
protect
lactogen
immun
piglet
therebi
reduc
mortal
morbid
fecal
shed
viru
south
korea
multipledos
vaccin
program
includ
lkk
interv
deliveri
recommend
nationwid
pregnant
sow
decad
due
absenc
new
safe
effect
live
vaccin
control
oral
exposur
feedback
primeboost
vaccin
strategi
mostli
implement
countermeasur
field
sinc
ped
epidem
despit
certain
posit
contribut
feedback
herd
intent
infect
use
undefin
inoculum
may
caus
undesir
neg
consequ
includ
insuffici
immun
induct
unexpect
viru
transmiss
amplifi
viral
recombin
divers
importantli
dissemin
microbi
pathogen
conceiv
evolv
develop
new
diseas
agent
coldadapt
mlv
vaccin
suppli
market
gradual
withdraw
feedback
practic
immin
sinc
oral
administr
capac
ensur
anim
immun
proper
dose
demerit
amelior
easili
use
live
vaccin
field
condit
avail
inactiv
pedv
vaccin
domest
market
custom
vaccin
program
applic
heterolog
oral
primeparenter
boost
lkk
llk
scheme
could
establish
base
variou
herd
circumst
includ
epidem
endem
status
noteworthi
matern
vaccin
implement
conjunct
addit
intervent
strategi
involv
intens
biosecur
husbandri
hygien
practic
ped
prevent
erad
